这篇论文引用了94615次,是不是该刊引用最高的的一篇论文,有待查证。 Nature Volume 227, Issue 5259, 1970, Pages 680-685 ISSN: 00280836 DOI: 10.1038/227680a0 PubMed ID: 5432063 Document Type: Article Source Type: Journal View at publisher | Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Laemmli, U.K. MRC Laboratory of Molecular Biology, Hills Road, Cambridge Abstract Using an improved method of gel electrophoresis, many hitherto unknown proteins have been found in bacteriophage T4 and some of these have been identified with specific gene products. Four major components of the head are cleaved during the process of assembly, apparently after the precursor proteins have assembled into some large intermediate structure. 1970 Nature Publishing Group. Language of original document English Index Keywords EMTREE drug terms: carbon; virus protein EMTREE medical terms: article ; autoradiography; coliphage; gel electrophoresis; kinetics; metabolism; microbial genetics; structural gene MeSH: Autoradiography; Carbon Isotopes; Coliphages; Electrophoresis, Disc; Genes, Structural; Genetics, Microbial; Kinetics; Viral Proteins Medline is the source for the MeSH terms of this document. Chemicals and CAS Registry Numbers carbon, 7440-44-0; Carbon Isotopes; Viral Proteins Gadget timed out while loading Laemmli, U.K.; MRC Laboratory of Molecular Biology, Hills Road, Cambridge, Copyright 2007 Elsevier B.V., All rights reserved. Nature Volume 227, Issue 5259, 1970, Pages 680-685 Cited by since 1996 This article has been cited 94615 times in Scopus: SCPUPS 数据库 1996至今 引用了94615次 (Showing the 2 most recent) Hfner, A.-K. , Cernescu, M. , Hofmann, B. Dimerization of human 5-lipoxygenase (2012) Biological Chemistry Ordiales, E. , Martín, A. , Benito, M.J. Technological characterisation by free zone capillary electrophoresis (FCZE) of the vegetable rennet (Cynara cardunculus) used in "torta del Casar" cheese-making (2012) Food Chemistry View details of all 94615 citations Inform me when this document is cited in Scopus: Set alert | Set feed Other citing sources Web: 10069 times 网络引用 10069次 Patents: 9241 times 专利引用9241次 http://www.scopus.com/record/display.url?eid=2-s2.0-0014949207origin=resultslistsort=cp-fsrc=snlo=nlr=nls=mltEid=2-s2.0-0033515827mltType=keymltAll=timp=tsid=BNSE5fIFNGEH_CLZIqvQ8Z3%3a490sot=mltsdt=mltsl=639s=TITLE-ABS-KEY%28%28%22article%22%29+OR+%28%22bone+marrow+cell%22%29+OR+%28%22cell+differentiation%22%29+OR+%28%22cell+lineage%22%29+OR+%28%22controlled+study%22%29+OR+%28%22human%22%29+OR+%28%22human+cell%22%29+OR+%28%22mesenchyme%22%29+OR+%28%22normal+human%22%29+OR+%28%22priority+journal%22%29+OR+%28%22stem+cell%22%29+OR+%28%22stroma+cell%22%29+OR+%28%22Adipocytes%22%29+OR+%28%22Adult%22%29+OR+%28%22Apoptosis%22%29+OR+%28%22Bone+Marrow+Cells%22%29+OR+%28%22Cell+Differentiation%22%29+OR+%28%22Cell+Division%22%29+OR+%28%22Cell+Lineage%22%29+OR+%28%22Cell+Separation%22%29+OR+%28%28+%22Cells%22+%22Cultured%22+%29%29+OR+%28%22Chondrocytes%22%29+OR+%28%22Fibroblasts%22%29+OR+%28%22Flow+Cytometry%22%29+OR+%28%22Humans%22%29+OR+%28%22Mesoderm%22%29+OR+%28%22Middle+Aged%22%29+OR+%28%22Osteocytes%22%29+OR+%28%22Phenotype%22%29+OR+%28%22Stem+Cells%22%29%29+AND+NOT+EID+%282-s2.0-0033515827%29relpos=0relpos=0searchTerm=TITLE-ABS-KEY((\"article\")%20OR%20(\"bone%20marrow%20cell\")%20OR%20(\"cell%20differentiation\")%20OR%20(\"cell%20lineage\")%20OR%20(\"controlled%20study\")%20OR%20(\"human\")%20OR%20(\"human%20cell\")%20OR%20(\"mesenchyme\")%20OR%20(\"normal%20human\")%20OR%20(\"priority%20journal\")%20OR%20(\"stem%20cell\")%20OR%20(\"stroma%20cell\")%20OR%20(\"Adipocytes\")%20OR%20(\"Adult\")%20OR%20(\"Apoptosis\")%20OR%20(\"Bone%20Marrow%20Cells\")%20OR%20(\"Cell%20Differentiation\")%20OR%20(\"Cell%20Division\")%20OR%20(\"Cell%20Lineage\")%20OR%20(\"Cell%20Separation\")%20OR%20((%20\"Cells\"%20\"Cultured\"%20))%20OR%20(\"Chondrocytes\")%20OR%20(\"Fibroblasts\")%20OR%20(\"Flow%20Cytometry\")%20OR%20(\"Humans\")%20OR%20(\"Mesoderm\")%20OR%20(\"Middle%20Aged\")%20OR%20(\"Osteocytes\")%20OR%20(\"Phenotype\")%20OR%20(\"Stem%20Cells\"))%20AND%20NOT%20EID%20(2-s2.0-0033515827 )
发表的期刊和年份 Journal of the American Medical Association Volume 289, Issue 19, 21 May 2003, Pages 2560-2572 ISSN: 00987484 CODEN: JAMAA DOI: 10.1001/jama.289.19.2560 PubMed ID: 12748199 Document Type: Review Source Type: Journal View references(81) View at publisher | The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report Chobanian, A.V. b , Bakris, G.L. c , Black, H.R. c , Cushman, W.C. d , Green, L.A. e , Izzo Jr., J.L. f , Jones, D.W. g , Materson, B.J. h , Oparil, S. i , Wright Jr., J.T. j , Roccella, E.J. a a Natl. Heart, Lung, and Blood Inst., National Institutes of Health, Natl. High Blood Pressure Educ. Pro., 31 Center Dr, Bethesda, MD 20892, United States b Department of Medicine, Boston University School of Medicine, Boston, MA, United States c Department of Preventive Medicine, Rush-Presbyterian-St Luke Med. Ctr., Chicago, IL, United States d Veterans Affairs Medical Center, Dept. of Prev. Medicine and Medicine, Univ. of Tennessee Hlth. Sci. Center, Memphis, TN, United States e Department of Family Medicine, University of Michigan, Ann Arbor, MI, United States f Dept. of Medicine and Pharmacology, State University of New York, Buffalo School of Medicine, Buffalo, NY, United States g Department of Medicine, Ctr. Excellence Cardio.-Renal Res., Univ. of Mississippi Medical Center, Jackson, MS, United States h Department of Medicine, Univ. of Miami School of Medicine, Miami, FL, United States i Dept. of Med., Physiol./Biophys., Division of Cardiovascular Disease, University of Alabama, Birmingham, AL, United States j Department of Medicine, University Hospitals of Cleveland, L. S. Cleveland Vet. Aff. Med. Ctr., Cleveland, OH, United States Abstract "The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure" provides a new guideline for hypertension prevention and management. The following are the key messages: (1) In persons older than 50 years, systolic blood pressure (BP) of more than 140 mm Hg is a much more important cardiovascular disease (CVD) risk factor than diastolic BP; (2) The risk of CVD, beginning at 115/75 mm Hg, doubles with each increment of 20/10 mm Hg; individuals who are normotensive at 55 years of age have a 90% lifetime risk for developing hypertension; (3) Individuals with a systolic BP of 120 to 139 mm Hg or a diastolic BP of 80 to 89 mm Hg should be considered as prehypertensive and require health-promoting lifestyle modifications to prevent CVD; (4) Thiazide-type diuretics should be used in drug treatment for most patients with uncomplicated hypertension, either alone or combined with drugs from other classes. Certain high-risk conditions are compelling indications for the initial use of other antihypertensive drug classes (angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, β-blockers, calcium channel blockers); (5) Most patients with hypertension will require 2 or more antihypertensive medications to achieve goal BP (140/90 mm Hg, or 130/80 mm Hg for patients with diabetes or chronic kidney disease); (6) If BP is more than 20/10 mm Hg above goal BP, consideration should be given to initiating therapy with 2 agents, 1 of which usually should be a thiazide-type diuretic; and (7) The most effective therapy prescribed by the most careful clinician will control hypertension only if patients are motivated. Motivation improves when patients have positive experiences with and trust in the clinician. Empathy builds trust and is a potent motivator. Finally, in presenting these guidelines, the committee recognizes that the responsible physician's judgment remains paramount. Language of original document English Index Keywords EMTREE drug terms: angiotensin receptor antagonist; antihypertensive agent; beta adrenergic receptor blocking agent; calcium channel blocking agent; dipeptidyl carboxypeptidase inhibitor; thiazide diuretic agent; alpha adrenergic receptor blocking agent; alpha adrenergic receptor stimulating agent; angiotensin receptor; diuretic agent; vasodilator agent EMTREE medical terms: age; blood pressure measurement; cardiovascular disease; cardiovascular risk; chronic kidney disease; comorbidity; diabetes mellitus; diastolic blood pressure; empathy; high risk population; human; hypertension; lifestyle; motivation; patient compliance; practice guideline; priority journal; review; risk factor; systolic blood pressure; treatment planning; algorithm; article; blood pressure; diagnostic test; drug antagonism; monitor; risk reduction MeSH: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Algorithms; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Blood Pressure Monitors; Calcium Channel Blockers; Cardiovascular Diseases; Diagnostic Tests, Routine; Diuretics; Humans; Hypertension; Receptors, Angiotensin; Risk Factors; Risk Reduction Behavior; Vasodilator Agents Medline is the source for the MeSH terms of this document. Chemicals and CAS Registry Numbers Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Diuretics; Receptors, Angiotensin; Vasodilator Agents References (81) View in table layout Cited by since 1996 This article has been cited 7003 times in Scopus: SCOPUS数据库统计 1996年至今引用了7003次 (Showing the 2 most recent) Sarafidis, P.A. , Georgianos, P.I. , Germanidis, G. Hypertension and symptomatic hypokalemia in a patient with simultaneous unilateral stenoses of intrarenal arteries and mesangioproliferativ... glomerulonephritis (2012) American Journal of Kidney Diseases Hermida, R.C. , Ayala, D.E. , Mojón, A. Sleep-time blood pressure and the prognostic value of isolated-office and masked hypertension (2012) American Journal of Hypertension View details of all 7003 citations Inform me when this document is cited in Scopus: Set alert | Set feed Other citing sources Web: 242 times 网络引用 242次 Patents: 11 times 专利引用 11次 http://www.scopus.com/record/display.url?eid=2-s2.0-0038460302origin=inwardtxGid=BNSE5fIFNGEH_CLZIqvQ8Z3%3a2
检索时间:2011-12-26 9,807 Documents that cite: Set feed 文献引用 Turner R. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) (1998) Lancet ,352(9131),pp.837-853. 349 Web pages that cite: 网络引用 Covered web sources: University repositories (e.g. MIT, DiVA, Caltech), theses dissertations. Web results brought to you by: for scientific information only 87 Patents that cite: 专利引用 Covered patent sources: US and European Patent offices, World Intellectual Property Organization. For more in-depth patent information click here: http://www.scopus.com/record/display.url?eid=2-s2.0-0032511583origin=resultslistsort=r-fcite=2-s2.0-0032511583src=pnlo=nlr=nls=imp=tsid=p2I6nlBhdhtkRZhOTxlpHxu%3a130sot=citesdt=asl=0 http://www.thelancet.com/ Most cited in The Lancet since 1996 1. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Research (1998) Lancet 352 (9131), pp. 837-853 Full text | PDF | Cited 9,378 times 还有这四篇大牛文 2. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: A randomised placebo-controlled trial Research (2002) Lancet 360 (9326), pp. 7-22 Full text | PDF | Cited 4,592 times 3. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial Research (1998) Lancet 351 (9118), pp. 1755-1762 Full text | PDF | Cited 3,643 times 4. Peginterferon alfa-2b plus ribavirin compared with interferonalfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial Research (2001) Lancet 358 (9286), pp. 958-965 Full text | PDF | Cited 3,604 times 5. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) Research (1996) Lancet 348 (9038), pp. 1329-1339 Full text | PDF | Cited 3,404 times